Labetalol Hydrochloride
- Product NDC
- 24979-170
- 11-digit product format
- 249790170
- Labeler code
- 24979
- Product ID
- 24979-170_03d305c1-fb1e-4c39-b743-157ae33343dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Labetalol Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- TWi Pharmaceuticals, Inc.
- Application
- ANDA209603
- Marketing category
- ANDA
- Marketing start
- 2018-08-01
- Marketing end
- 0000-00-00
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 24979-170-01 | 24979017001 | 100 TABLET, FILM COATED in 1 BOTTLE (24979-170-01) | 2018-08-01 | 0000-00-00 | No | No | Current |
| 24979-170-02 | 24979017002 | 500 TABLET, FILM COATED in 1 BOTTLE (24979-170-02) | 2018-08-01 | 0000-00-00 | No | No | Current |
| 24979-170-06 | 24979017006 | 30 TABLET, FILM COATED in 1 BOTTLE (24979-170-06) | 2018-08-01 | 0000-00-00 | No | No | Current |